The cardioprotective mechanisms of draconis sanguis: An integrated network pharmacology, bioinformatics, and experimental validation study

Objective: To investigate the potential targets and mechanisms of Draconis Sanguis (DS), a valuable traditional Chinese medicine derived from the resin of the palm tree Daemonorops draco Bl (D. Sanguis, Xue Jie), in the treatment of myocardial infarction (MI). Methods: We explored the potential mech...

Full description

Saved in:
Bibliographic Details
Main Authors: Keyan Wang, Rongxin Zhu, Junjun Li, Binhua Yuan, Xiang Li, Yunlin Li, Mingyue Huang, Fangfang Rui, Chun Li, Wei Wang
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Journal of Traditional Chinese Medical Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2095754825000547
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849246094788132864
author Keyan Wang
Rongxin Zhu
Junjun Li
Binhua Yuan
Xiang Li
Yunlin Li
Mingyue Huang
Fangfang Rui
Chun Li
Wei Wang
author_facet Keyan Wang
Rongxin Zhu
Junjun Li
Binhua Yuan
Xiang Li
Yunlin Li
Mingyue Huang
Fangfang Rui
Chun Li
Wei Wang
author_sort Keyan Wang
collection DOAJ
description Objective: To investigate the potential targets and mechanisms of Draconis Sanguis (DS), a valuable traditional Chinese medicine derived from the resin of the palm tree Daemonorops draco Bl (D. Sanguis, Xue Jie), in the treatment of myocardial infarction (MI). Methods: We explored the potential mechanisms of DS in the treatment of MI using network pharmacology, bioinformatic techniques, and transcriptomic analysis, followed by validation through in vivo and in vitro experiments. Results: Network pharmacology and bioinformatic analyses identified five genes (Fpr1, Glul, Mme, Mmp9, and Pla2g7) as potential targets for MI treatment. Moreover, DS significantly ameliorated cardiac function, inflammatory responses, and MI-induced myocardial fibrosis in vivo. Transcriptomic and bioinformatic analyses identified Pla2g7 as the most critical target in the DS treatment of MI. Molecular docking revealed that the key active ingredient in DS has a strong affinity for this gene. Furthermore, DS reduced the expression of Pla2g7 (P = .0009), NLRP3 (P = .003), interleukin-18 (P < .001), and interleukin-1β (P = .004) mRNAs in vivo. Conclusions: The results indicate that DS can downregulate the expression of Pla2g7 and reduce the inflammatory response. This demonstrates the potential therapeutic target of DS and the mechanism underlying its cardioprotective effects.
format Article
id doaj-art-5343b024b01d4c6ca110d20d132c2d44
institution Kabale University
issn 2095-7548
language English
publishDate 2025-07-01
publisher Elsevier
record_format Article
series Journal of Traditional Chinese Medical Sciences
spelling doaj-art-5343b024b01d4c6ca110d20d132c2d442025-08-20T03:58:36ZengElsevierJournal of Traditional Chinese Medical Sciences2095-75482025-07-0112333634710.1016/j.jtcms.2025.05.004The cardioprotective mechanisms of draconis sanguis: An integrated network pharmacology, bioinformatics, and experimental validation studyKeyan Wang0Rongxin Zhu1Junjun Li2Binhua Yuan3Xiang Li4Yunlin Li5Mingyue Huang6Fangfang Rui7Chun Li8Wei Wang9School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, ChinaSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, ChinaSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, ChinaSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, ChinaSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, ChinaSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, ChinaSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, ChinaSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, ChinaBeijing Key Laboratory of Traditional Chinese Medicine Syndrome and Formula, Beijing University of Chinese Medicine, Beijing 102488, China; Modern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, China; Corresponding authors.State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Corresponding authors.Objective: To investigate the potential targets and mechanisms of Draconis Sanguis (DS), a valuable traditional Chinese medicine derived from the resin of the palm tree Daemonorops draco Bl (D. Sanguis, Xue Jie), in the treatment of myocardial infarction (MI). Methods: We explored the potential mechanisms of DS in the treatment of MI using network pharmacology, bioinformatic techniques, and transcriptomic analysis, followed by validation through in vivo and in vitro experiments. Results: Network pharmacology and bioinformatic analyses identified five genes (Fpr1, Glul, Mme, Mmp9, and Pla2g7) as potential targets for MI treatment. Moreover, DS significantly ameliorated cardiac function, inflammatory responses, and MI-induced myocardial fibrosis in vivo. Transcriptomic and bioinformatic analyses identified Pla2g7 as the most critical target in the DS treatment of MI. Molecular docking revealed that the key active ingredient in DS has a strong affinity for this gene. Furthermore, DS reduced the expression of Pla2g7 (P = .0009), NLRP3 (P = .003), interleukin-18 (P < .001), and interleukin-1β (P = .004) mRNAs in vivo. Conclusions: The results indicate that DS can downregulate the expression of Pla2g7 and reduce the inflammatory response. This demonstrates the potential therapeutic target of DS and the mechanism underlying its cardioprotective effects.http://www.sciencedirect.com/science/article/pii/S2095754825000547Myocardial infarctionDraconis sanguisNetwork pharmacologyBioinformaticsRNA-seqPla2g7
spellingShingle Keyan Wang
Rongxin Zhu
Junjun Li
Binhua Yuan
Xiang Li
Yunlin Li
Mingyue Huang
Fangfang Rui
Chun Li
Wei Wang
The cardioprotective mechanisms of draconis sanguis: An integrated network pharmacology, bioinformatics, and experimental validation study
Journal of Traditional Chinese Medical Sciences
Myocardial infarction
Draconis sanguis
Network pharmacology
Bioinformatics
RNA-seq
Pla2g7
title The cardioprotective mechanisms of draconis sanguis: An integrated network pharmacology, bioinformatics, and experimental validation study
title_full The cardioprotective mechanisms of draconis sanguis: An integrated network pharmacology, bioinformatics, and experimental validation study
title_fullStr The cardioprotective mechanisms of draconis sanguis: An integrated network pharmacology, bioinformatics, and experimental validation study
title_full_unstemmed The cardioprotective mechanisms of draconis sanguis: An integrated network pharmacology, bioinformatics, and experimental validation study
title_short The cardioprotective mechanisms of draconis sanguis: An integrated network pharmacology, bioinformatics, and experimental validation study
title_sort cardioprotective mechanisms of draconis sanguis an integrated network pharmacology bioinformatics and experimental validation study
topic Myocardial infarction
Draconis sanguis
Network pharmacology
Bioinformatics
RNA-seq
Pla2g7
url http://www.sciencedirect.com/science/article/pii/S2095754825000547
work_keys_str_mv AT keyanwang thecardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT rongxinzhu thecardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT junjunli thecardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT binhuayuan thecardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT xiangli thecardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT yunlinli thecardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT mingyuehuang thecardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT fangfangrui thecardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT chunli thecardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT weiwang thecardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT keyanwang cardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT rongxinzhu cardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT junjunli cardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT binhuayuan cardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT xiangli cardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT yunlinli cardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT mingyuehuang cardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT fangfangrui cardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT chunli cardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy
AT weiwang cardioprotectivemechanismsofdraconissanguisanintegratednetworkpharmacologybioinformaticsandexperimentalvalidationstudy